INSY

Insys Therapeutics, Inc.
INSY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

98 hedge funds and large institutions have $51.6M invested in Insys Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

45% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 29

Holders
98
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$724K
Puts
$1.24M
Net Calls
Net Calls Change

Top Buyers

1
+$3.03M
2
+$2.65M
3
+$1.23M
4
PAM
Panagora Asset Management
Massachusetts
+$672K
5
Citadel Advisors
Citadel Advisors
Florida
+$468K

Top Sellers

1
-$5.08M
2
-$2.19M
3
-$866K
4
BlackRock
BlackRock
New York
-$531K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$3K
77
$2K
78
$2K
79
$2K
80
$2K
81
$2K
82
$1K
83
$1K
84
$1K
85
$1K
86
$1K
87
$1K
88
$1K
89
$1K
90
$554
91
$300
92
–
93
–
94
–
95
–
96
–
97
–
98
–
99
–
100
–
1 2 3
4
5